HCPCS Level II
J1628
Injection, guselkumab, 1 mg
Codes near J1628
These sit next to J1628 in the CMS Level II file. All J codes
- J1611Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg
- J1612Injection, glucagon (gvoke), 0.01 mg
- J1620Injection, gonadorelin hydrochloride, per 100 mcg
- J1626Injection, granisetron hydrochloride, 100 mcg
- J1627Injection, granisetron, extended-release, 0.1 mg
- J1630Injection, haloperidol, up to 5 mg
- J1631Injection, haloperidol decanoate, per 50 mg
- J1632Injection, brexanolone, 1 mg
- J1640Injection, hemin, 1 mg
- J1642Injection, heparin sodium, (heparin lock flush), per 10 units
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 57894-0640-01 | Tremfya | Janssen Biotech, Inc. | 100 |
| 57894-0640-06 | Tremfya | Janssen Biotech, Inc. | 100 |
| 57894-0640-11 | Tremfya | Janssen Biotech, Inc. | 100 |
| 57894-0650-02 | Tremfya | Janssen Biotech, Inc. | 200 |
| 57894-0651-02 | Tremfya | Janssen Biotech, Inc. | 200 |
| 57894-0651-04 | Tremfya | Janssen Biotech, Inc. | 400 |
| 57894-0651-22 | Tremfya | Janssen Biotech, Inc. | 200 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.